RePORT International Resources

This CDC website provides comprehensive information on TB, including symptoms, testing, treatment, prevention, and resources for healthcare providers, public health professionals, and the general public.

This insightful CFAR seminar, presented by Dr. Richard Chaisson, tackles the critical question: is global tuberculosis elimination a realistic goal or an overly ambitious dream? Drawing on data and clinical experience, he examines key challenges in TB control—such as diagnostics, treatment access, and systemic barriers—while highlighting strategic priorities for meaningful progress. A must-watch for those working in TB, HIV, and public health.

Most important training for any investigator would be HSP/GCP where they need to learn and understand how Ethical conduct of research is done and why it is important. DAIDS learning portal, HANC network , DAIDS score manual have good training modules .

The Collaborative Institutional Training Initiative (CITI Program) is dedicated to serving the training needs of colleges and universities, healthcare institutions, technology and research organizations, and governmental agencies, as they foster integrity and professional advancement of their learners.

Association of American Medical Colleges- Webinar recording on Communication Science

NOTE: Candidate application for Class 23 (2025-2027) is closed but refer to the websites for future calls. Council of State and Territorial Epidemiologists (CSTE) established the Applied Epidemiology Fellowship (AEF) which is closely designed after the Epidemic Intelligence Service (EIS) program and using a mentorship model to train recent graduates in the expanding field of applied epidemiology. Participating fellows will receive two years of on-the-job training at a state or local health department under the guidance of two experienced mentors.

Covidence is a web-based software platform designed to streamline the process of conducting systematic reviews and other comprehensive literature reviews. It facilitates tasks such as citation screening, full-text review, risk of bias assessment, data extraction, and export of data and references.

This podcast features Dr. Valwynne Faulkner, a postdoctoral researcher at the Francis Crick Institute and a LifeArc Knowledge Transfer Innovations Fellow. Her work bridges cutting-edge molecular biology and technology transfer. In this episode, she discusses her team's innovative use of CRISPR to uncover new strategies for tackling tuberculosis — including drug-resistant strains.

This document provides criteria for each diagnosis and a coding scheme for each diagnoses including levels of evidence confirmed, probable and no distinction between confirmed and probable.

“Defeating Tuberculosis: An Adventure with Learning” is an educational booklet designed for children, presenting essential information about tuberculosis in a playful and interactive way. This English version was adapted from the original publication in Portuguese. The material introduces basic concepts of microbiology, highlighting the differences between viruses, bacteria, and fungi, and teaches key prevention measures such as vaccination and the importance of hygiene. Through interactive activities — including games, coloring pages, and challenges — the booklet encourages children to learn about TB symptoms, the importance of early diagnosis, and the role of health professionals in treatment. At the end, children receive a “Little Health Scientist Certificate”, reinforcing the message that everyone can contribute to the prevention and elimination of tuberculosis.

E.W. "Al" Thrasher Awards focus on projects that are changing pediatric clinical care. Each award is a novel approach to problems plaguing pediatrics. The award is open to applications focusing on any disease or topic within the umbrella of pediatrics, both in and outside the United States. Ideal applications for the Thrasher Award address significant health problems, offering the potential for practical solutions to these problems. Typically, the primary outcome is a health outcome in children. Solutions should be innovative and have the potential for broad applicability with low barriers to implementation. Projects with a shorter distance to clinical applicability are given priority.​

This tool is based on the Core Competencies in Applied Infectious Disease Epidemiology in Europe. This downloadable tool helps users assess their profile and identify relevant training in the ECDC Virtual Academy.

Free access to courses and training materials in infectious disease and public health, available for self-study or to support training others.

This report provides an overview of the latest tuberculosis (TB) epidemiological situation and is published jointly by the WHO Regional Office for ECDC.

The EDCTP Knowledge Hub is designed to equip researchers with the tools and guidance needed to conduct high-quality health research. It includes the Protocol Development Toolkit, Data Management Portal, Data Sharing Toolkit, and Research into Policy Toolkit—guiding researchers from formulating a question to sharing data and translating findings into policy and practice, all within key research frameworks.

Contact: Roger Ptak Roger.Ptak@nih.gov Objective: This new initiative aims to support investigator-led, multidisciplinary research to define how HIV-driven alterations to immunometabolism affect immune cell regulation, cell-cell interactions, response to treatment, and, ultimately, tuberculosis (TB) and hepatitis B virus (HBV) progression. Elucidating and subsequently probing such mechanisms will lead to identification of candidate biomarkers of disease progression and potential targets for immune-modulatory treatment (i.e., host-directed therapy) to decrease TB and HBV risk in people living with HIV. Description: This initiative will advance laboratory-based research to elucidate immunometabolic pathways and mechanisms that can be exploited for new therapeutic and diagnostic strategies.

The goal of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to a low- or middle-income country (LMIC) early career research scientist who holds a junior faculty position at an LMIC academic or research institution, as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups, including “low-income,” “lower-middle-income,” and “upper-middle-income” countries, with exceptions below (see Section III. Eligibility Information)). This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Notice of Funding Opportunity (NOFO) invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors. Please refer to the website for detail announcement and key dates.

APPLICATION DEADLINE: 14 October 2025 17:00:00 Brussels time Objectives The Starting Grant supports excellent Principal Investigators starting or having recently started their own independent research team or programme. A Starting Grant Principal Investigator should have already shown evidence of the potential for research independence, for example, by having produced at least one important publication as its main author or a publication without the participation of their PhD supervisor. Size of ERC Starting Grants Starting Grants may be awarded up to a maximum of EUR 1 500 000 for a period of 5 years. The maximum size of the grants is reduced pro rata temporis for proposals of shorter duration. Profile of the ERC Starting Grant Principal Investigator The Principal Investigators shall have successfully defended their first PhD at least 2 and up to 7 years prior to 1 January 2026. Cut-off dates: Successful defence of PhD between 1 January 2019 and 31 December 2023 (inclusive). The eligibility period can be extended beyond 7 years in certain properly documented circumstances. See section 1.4 Admissibility, Eligibility, Resubmission Restrictions of the ERC Work Programme 2026.

APPLICATION DEADLINE: 05 November 2025 17:00:00 Brussels time Objective: The aim is to provide support for a small group of two to four Principal Investigators to jointly address ambitious research problems that could not be addressed by the individual Principal Investigators and their teams working alone. Synergy projects should enable substantial advances at the frontiers of knowledge, stemming, for example, from the cross-fertilization of scientific fields, from new productive lines of enquiry, or new methods and techniques, including unconventional approaches and investigations at the interface between established disciplines. The transformative research funded by Synergy Grants should have the potential of becoming a benchmark on a global scale. Principal Investigators must demonstrate the ground-breaking nature, ambition and feasibility of their scientific proposal. Principal Investigators must also demonstrate that their group can successfully bring together the scientific elements necessary to address the scope and complexity of the proposed research question. One of the Principal Investigators must be designated as the Corresponding Principal Investigator. At any one time, one Principal Investigator per Synergy Grant Group except the Corresponding one can be hosted or engaged by an institution outside of the EU or Associated Countries. Size of ERC Synergy Grants Synergy Grants may be awarded up to a maximum of EUR 10 000 000 for a period of 6 years. The maximum award is reduced pro rata temporis for projects of a shorter duration. This does not apply to ongoing projects. Profile of the ERC Synergy Grant Principal Investigators The 'Synergy Grant Group' applying for the ERC Synergy Grant must be made up of a minimum of two and a maximum of four Principal Investigators with competitive track records and, as necessary, their teams. Each of the Principal Investigators must present in the proposal a Curriculum Vitae and a Track Record as appropriate to their career stage. For further information, please see the ERC Work Programme 2026.

The European Research Council (ERC) is a funding organisation for frontier research. It aims to stimulate scientific excellence in Europe by funding the very best, creative researchers of any nationality and age, and supporting their innovative ideas. Researchers from anywhere in the world can apply for ERC grants provided the research they undertake will be carried out in an EU Member State or Associated Country.